Skip to main content
Premium Trial:

Request an Annual Quote

KeyGene, Biogemma Ink Bioinformatics Alliance

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - KeyGene and Biogemma announced today that they will collaborate on data integration and mining of genomics and genetic information for sequence-based plant breeding.

The alliance will combine KeyGene's capabilities in molecular breeding, genomics, and sequence-based molecular analysis with Biogemma's technologies in genomics, functional genomics, and gene-based approaches in field crops.

Biogemma, in collaboration with other partners, has developed genetic databases, genomics technologies, and molecular marker libraries for numerous field crops. Biogemma and KeyGene intend to combine their methodologies and bioinformatics technologies for improved analysis of these databases and gene mining for the benefit of both Biogemma and KeyGene customers.

"Data resources in plant breeding are not the major bottleneck anymore," Harold Verstegen, head of KeyGene's bioinformatics department, said in a statement. "This also holds true for data integration capabilities. However, enabling efficient data analysis from a breeding perspective is still a major challenge and therefore new solutions are needed for decision support in breeding programs."

Financial and other terms of the alliance were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more